Shilpa Biocare Invests in Gate2Brain to Advance G2B-002, an Innovative Brain Cancer Therapeutic Candidate

by BStartup

Shilpa Biocare has become a strategic shareholder in Gate2Brain through a €7 million investment corresponding to a 30.4% equity stake. The partnership represents a major milestone for Gate2Brain and...

Read more
Subscribe to Directory
Write an Article

Highlight

Axon moves into Cloud Technology

by Axon Partners Group

cloud technology axon

19th Edition of the Spain Private Equity...

by SpainCap

Axon Partners Group, Tresmares Capital, Sabadell Venture Capital, Inve...

Photos Stream